BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12169678)

  • 1. A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.
    Hosaka T; Nakashima Y; Kusuzaki K; Murata H; Nakayama T; Nakamata T; Aoyama T; Okamoto T; Nishijo K; Araki N; Tsuboyama T; Nakamura T; Toguchida J
    J Mol Diagn; 2002 Aug; 4(3):164-71. PubMed ID: 12169678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas.
    Huang HY; Antonescu CR
    Ultrastruct Pathol; 2003; 27(4):217-26. PubMed ID: 12907366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
    Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
    Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
    Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
    Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
    Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel type of EWS-CHOP fusion gene in myxoid liposarcoma.
    Matsui Y; Ueda T; Kubo T; Hasegawa T; Tomita Y; Okamoto M; Myoui A; Kakunaga S; Yasui N; Yoshikawa H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):437-40. PubMed ID: 16884691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.
    Antonescu CR; Elahi A; Humphrey M; Lui MY; Healey JH; Brennan MF; Woodruff JM; Jhanwar SC; Ladanyi M
    J Mol Diagn; 2000 Aug; 2(3):132-8. PubMed ID: 11229517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
    Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
    Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.
    Dal Cin P; Sciot R; Panagopoulos I; Aman P; Samson I; Mandahl N; Mitelman F; Van den Berghe H; Fletcher CD
    J Pathol; 1997 Aug; 182(4):437-41. PubMed ID: 9306965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoid liposarcoma with EWS-CHOP type 1 fusion gene.
    Suzuki K; Matsui Y; Endo K; Kubo T; Hasegawa T; Kimura T; Ohtani O; Yasui N
    Anticancer Res; 2010 Nov; 30(11):4679-83. PubMed ID: 21115923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP.
    Zinszner H; Albalat R; Ron D
    Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
    Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
    Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
    Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
    Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas.
    Oikawa K; Ishida T; Imamura T; Yoshida K; Takanashi M; Hattori H; Ishikawa A; Fujita K; Yamamoto K; Matsubayashi J; Kuroda M; Mukai K
    Am J Surg Pathol; 2006 Mar; 30(3):351-6. PubMed ID: 16538055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic sequence motifs located at the genomic breakpoints of the translocation t(12;16) and t(12;22) in myxoid liposarcoma.
    Xiang H; Wang J; Hisaoka M; Zhu X
    Pathology; 2008 Oct; 40(6):547-52. PubMed ID: 18752119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
    Panagopoulos I; Aman P; Mertens F; Mandahl N; Rydholm A; Bauer HF; Mitelman F
    Genes Chromosomes Cancer; 1996 Oct; 17(2):102-7. PubMed ID: 8913727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
    Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
    Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
    de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
    Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel FUS/CHOP chimera in myxoid liposarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Biochem Biophys Res Commun; 2000 Dec; 279(3):838-45. PubMed ID: 11162437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.